Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Haskell

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Chest|June 1, 1991
Chemotherapy and survival of patients with non-small cell lung cancer. A contrary viewC M Haskell
Lancet (London, England)|July 25, 1981
Significance of splenic vascular invasion in Hodgkin's diseaseC M Haskell
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis and midline malignancies of uncertain originC M Haskell
Annual Review of Pharmacology and Toxicology|January 1, 1977
Immunologic aspects of cancer chemotherapyC M Haskell
The Medical Clinics of North America|September 1, 1977
Management of metastatic breast cancerC M Haskell
Cancer Treatment Reports|January 1, 1981
L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasmsC M Haskell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Ethics in oncology textbooksC M Haskell
Cancer Investigation|January 1, 1987
Systemic therapy for micrometastatic breast cancerT Lindgren, C M Haskell
Cancer Research|November 1, 1974
Comparative survival in tissue culture of normal and neoplastic human cells exposed to adriamycinC M Haskell, A Sullivan
Cancer Treatment Reports|May 1, 1982
Inadvertent overdose with lomustine (CCNU) followed by hematologic recoveryK A Foon, C M Haskell
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Chest|June 1, 1991
Chemotherapy and survival of patients with non-small cell lung cancer. A contrary viewC M Haskell
Lancet (London, England)|July 25, 1981
Significance of splenic vascular invasion in Hodgkin's diseaseC M Haskell
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis and midline malignancies of uncertain originC M Haskell
Annual Review of Pharmacology and Toxicology|January 1, 1977
Immunologic aspects of cancer chemotherapyC M Haskell
The Medical Clinics of North America|September 1, 1977
Management of metastatic breast cancerC M Haskell
Cancer Treatment Reports|January 1, 1981
L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasmsC M Haskell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Ethics in oncology textbooksC M Haskell
Cancer Investigation|January 1, 1987
Systemic therapy for micrometastatic breast cancerT Lindgren, C M Haskell
Cancer Research|November 1, 1974
Comparative survival in tissue culture of normal and neoplastic human cells exposed to adriamycinC M Haskell, A Sullivan
Cancer Treatment Reports|May 1, 1982
Inadvertent overdose with lomustine (CCNU) followed by hematologic recoveryK A Foon, C M Haskell
Pageof 5